Tuberculosis associated with Mycobacterium tuberculosis Beijing and non-Beijing genotypes: A clinical and immunological comparison

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Sun, Yong Jiang ^a   Lim, T K ^b   Ong, Adrian Kheng Yeow ^a   Ho, Benjamin Choon Heng ^a   Seah, Geok Teng ^b   Paton, Nicholas I ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ETHAMBUTOL; GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 4; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADULT; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; CELLULAR IMMUNITY; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; FEMALE; FEVER; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; LUNG CAVITATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NIGHT SWEAT; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; STRAIN DIFFERENCE; TH1 CELL; TH2 CELL; UNIVARIATE ANALYSIS;

ADULT; BIOLOGICAL MARKERS; CHINA; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMANS; LUNG; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TH2 CELLS; TUBERCULOSIS, PULMONARY;

EID: 33747724593     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-105     Document Type: Article

References (29)

1. van Soolingen D, Qian L, de Haas PE, Douglas JT, Traore H, Portaels F, Qing HZ, Enkhsaikan D, Nymadawa P, van Embden JD: Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. J Clin Microbiol 1995, 33:3234-3238.
2. Anh DD, Borgdorff MW, Van LN, Lan NT, van Gorkom T, Kremer K, van Soolingen D: Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis 2000, 6:302-305.
3. Park YK, Bai GH, Kim SJ: Restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolated from countries in the western pacific region. J Clin Microbiol 2000, 38:191-197.
4. Chan MY, Borgdorff M, Yip CW, de Haas PE, Wong WS, Kam KM, van Soolingen D: Seventy percent of the Mycobacterium tuberculosis isolates in Hong Kong represents the Beijing genotype. Epidemiol Infect 2001, 127:169-171.
5. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN: Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol 2002, 10:45-52.
6. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D: Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002, 8:843-849.
7. Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey ML, Moghazeh SL, Eisner W, Daniel TM, Kaplan MH, Crawford JT, Musser JM, Kreiswirth BN: Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 1996, 275:452-457.
8. Diaz R, Kremer K, de Haas PE, Gomez RI, Marrero A, Valdivia JA, van Embden JD, van Soolingen D: Molecular epidemiology of tuberculosis in Cuba outside of Havana, July 1994-June 1995: utility of spoligotyping versus IS6110 restriction fragment length polymorphism. Int J Tuberc Lung Dis 1998, 2:743-750.
9. Kruuner A, Hoffner SE, Sillastu H, Danilovits M, Levina K, Svenson SB, Ghebremichaell S, Koivula T, Kallenius G: Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol 2001, 39:3339-3345.
10. Toungoussova OS, Mariandyshev A, Blune G, Sandven P, Caugant DA: Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family. Clin Infect Dis 2003, 37:665-672.
11. Lan NT, Lien HT, Tung B, Borgdorff MW, Kremer K, van Soolingen D: Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg Infect Dis 2003, 9:1633-1635.
12. van Crevel R, Nelwan RH, de Lenne W, Veeraragu Y, van der Zanden AG, Amin Z, van der Meer JW, van Soolingen D: Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. Emerg Infect Dis 2001, 7:880-883.
13. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, Barry CE 3rd, Freedman VH, Kaplan G: Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc Natl Acad Sci U S A 2001, 98:5752-5757.
14. Lopez B, Aguilar D, Orozco H, Burger M, Espitia C, Ritacco V, Barrera L, Kremer K, Hernandez-Pando R, Huygen K, van Soolingen D: A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 2003, 133:30-37.
15. Dale JW, Brittain D, Cataldi AA, Cousins D, Crawford JT, Driscoll J, Heersma H, Lillebaek T, Quitugua T, Rastogi N, Skuce RA, Sola C, van Soolingen D, Vincent V: Spacer oligonucleotide typing of bacteria of the Mycobacterium tuberculosis complex: recommendations for standardised nomenclature. Int J Tuberc Lung Dis 2001, 5:216-219.
16. Supply P, Lesjean S, Savine E, Kremer K, van Soolingen D, Locht C: Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J Clin Microbiol 2001, 39:3563-3571.
17. Sun YJ, Bellamy R, Lee ASG, Ng ST, Ravindran S. Wong S-Y, Locht C, Supply P, Paton NI: Use of mycobacterial interspersed repetitive unit-variable-number tandem repeat typing to examine genetic diversity of Mycobacterium tuberculosis in Singapore. J Clin Microbiol 2004, 42:1986-1993.
18. Filliol I, Driscoll JR, van Soolingen D, Kreiswirth BN, Kremer K, Valetudie G, Anh DD, Barlow R, Banerjee D, Bifani PJ, Brudey K, Cataldi A, Cooksey RC, Cousins DV, Dale JW, Dellagostin OA, Drobniewski F, Engelmann G, Ferdinand S, Gascoyne-Binzi D, Gordon M, Gutierrez MC, Haas WH, Heersma H, Kallenius G. Kassa-Kelembho E, Koivula T, Ly HM, Makristathis A, Mammina C, Martin G, Mostrom P, Mokrousov I, Narbonne V, Narvskaya O, Nastasi A, Niobe-Eyangoh SN, Pape JW, Rasolofo-Razanamparany V, Ridell M, Rossetti ML, Stauffer F, Suffys PN, Takiff H, Texier-Maugein J, Vincent V, de Waard JH, Sola C, Rastogi N: Global distribution of Mycobacterium tuberculosis spoligotypes. Emerg Infect Dis 2002, 8:1347-1349.
19. Kremer K, Glynn JR. Lillebaek T, Niemann S, Kurepina NE, Kreiswirth BN, Bifani PJ, van Soolingen D: Definition of the Beijing/W line-age age of Mycobacterium tuberculosis on the basis of genetic markers. J Clin Microbiol 2004, 42:4040-4049.
20. Arango L, Brewin AW, Murray JF: The spectrum of tuberculosis as currently seen in a metropolitan hospital. Am Rev Respir Dis 1973, 108:805-812.
21. Kiblawi S, Jay SO, Stonehill SJ, Norton RB: Fever response of patients on therapy for pulmonary tuberculosis. Am Rev Respir Dis 1981, 123:20-24.
22. Barnes PF, Chan LS, Wong SF: The course of fever during treatment of pulmonary tuberculosis. Tubercle 1987, 68:255-260.
23. Rathman G, Sillah J, Hill PC, Murray JF, Adegbola R, Corrah T, Lienhardt C, McAdam KP: Clinical and radiological presentation of 340 adults with smear-positive tuberculosis in The Gambia. Int J Tuberc Lung Dis 2003, 7:942-947.
24. Drobniewski F, Balabanova Y, Nikolayevsky V, Ruddy M, Kuznetzov S, Zakharova S, Melentyev & Fedorin I: Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 2005, 293:2726-2731.
25. Borgdorff MW, Van Deutekom H, De Haas PE, Kremer K, van Soolingen D: Mycobacterium tuberculosis, Beijing genotype strains not associated with radiological presentation of pulmonary tuberculosis. Tuberculosis (Edinb) 2004, 84:337-340.
26. Chacon-Salinas R, Serafin-Lopez J, Ramos-Payan R, Mendez-Aragon P, Hernandez-Pando R, Van Soolingen D, Flores-Romo L, Estrada-Parra S, Estrada-Garcia I: Differential pattern of cytokine expression by macrophages infected in vitro with difierent Mycobacterium tuberculosis genotypes. Clin Exp Immunol 2005, 140:443-449.
27. Seah GT, Scott GM, Rook GA: Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 2000, 181:385-389.
28. van Crevel R, Karyadi E, Prayers F, Leenders M, Kullberg BJ, Nelwan RH, van der Meer JW: Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J Infect Dis 2000, 181:1194-1197.
29. Ordway DJ, Costa L, Martins M, Silveira H, Amaral L, Arroz MJ, Ventura FA, Dockrell HM: Increased Interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis. J Infect Dis 2004, 190:756-766.